吴
吴迪 Chief Executive Officer
C-suite
FR FR · AMF
Discover the complete record of transactions filed by 吴迪, Chief Executive Officer. Insider active across 3 companies, notably 福鞍股份. Cumulatively, 46 reports have been recorded. The latest transaction was disclosed on 25 April 2025 — Purchase. Regulator: AMF. All data is free.
Declarations 46 total
80,000 shares
SSE:173000009835496400 · 27 Nov 2025
30,000 shares
SSE:173000009827576740 · 24 Nov 2025
30,000 shares
SSE:173000009783837660 · 17 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 8,000 shares
SSE:173000009783837730 · 17 Nov 2025
10,000 shares
SSE:173000009775577400 · 13 Nov 2025
69,900 shares
SSE:173000009738442370 · 11 Nov 2025
20,000 shares
SSE:173000009726371520 · 10 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 20,000 shares
SSE:173000009717809440 · 6 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 10,000 shares
SSE:173000009717809470 · 6 Nov 2025
6,000 shares
SSE:173000009717809800 · 6 Nov 2025
50,000 shares
SSE:173000009712471970 · 5 Nov 2025
Executives ● Purchase派 派林生物 18 SZSE €19,584 7,500 shares
SZSE:173000008868500580 · 25 Apr 2025
Ideal exit: 20 Jan 2026 (T+270) Executives ● Purchase派 派林生物 22 SZSE €13,056 5,000 shares
SZSE:173000008868500400 · 25 Apr 2025
Ideal exit: 20 Jan 2026 (T+270) Executives ● Purchase派 派林生物 7 SZSE €542 200 shares
SZSE:173000008717793300 · 24 Feb 2025
Ideal exit: 21 Nov 2025 (T+270) Executives ● Purchase派 派林生物 7 SZSE €5,572 2,000 shares
SZSE:173000008552387420 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €4,321 1,500 shares
SZSE:173000008451201340 · 14 Jan 2025
Ideal exit: 11 Oct 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €2,185 800 shares
SZSE:173000008409120800 · 7 Jan 2025
Ideal exit: 4 Oct 2025 (T+270) Executives ● Purchase派 派林生物 11 SZSE €27,529 10,000 shares
SZSE:173000008405393340 · 6 Jan 2025
Ideal exit: 3 Oct 2025 (T+270) Executives ● Purchase派 派林生物 7 SZSE €5,506 2,000 shares
SZSE:173000008405393300 · 6 Jan 2025
Ideal exit: 3 Oct 2025 (T+270) Executives ● Purchase派 派林生物 11 SZSE €14,076 5,000 shares
SZSE:173000008396452540 · 2 Jan 2025
Ideal exit: 29 Sept 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €5,631 2,000 shares
SZSE:173000008396452580 · 2 Jan 2025
Ideal exit: 29 Sept 2025 (T+270) Executives ● Purchase尤 尤夫股份 11 SZSE 5,700 shares
SZSE:173000008264542800 · 14 Nov 2024
Ideal exit: 11 Aug 2025 (T+270) Executives ● Purchase尤 尤夫股份 7 SZSE 4,000 shares
SZSE:173000008138114020 · 30 Sept 2024
Ideal exit: 27 Jun 2025 (T+270) Executives ● Purchase尤 尤夫股份 7 SZSE 8,000 shares
SZSE:173000007882566600 · 25 Jul 2024
Ideal exit: 21 Apr 2025 (T+270) Executives ● Sale派 派林生物 7 SZSE 3,500,000 shares
SZSE:173000006682573300 · 26 Jun 2023
25 of 46 declarations
Load more (21 remaining) About 吴迪 Wu Di is the General Manager and Director at Double Star New Materials and Pailin Biotechnology, two innovative companies in the field of advanced materials and biotechnology. With significant experience in business management, he plays a key role in the development strategy and governance of both companies. His commitment to innovation is essential for their success.